Using the 75th percentile, patients whose tumours had increased EGFR mRNA expression had significantly reduced OS (22 out of 67 deaths in EGFR-positive vs 38 out of 200 deaths in EGFR-negative patients, log-rank P=0.022) (Figure 2A1). The gene discussed is EGFR; the disease is neoplasm.